Reuters Health Report: August 24, 2017

Click to View in Browser Thursday, August 24, 2017 McDonald's to cut global antibiotic use in chickens LOS ANGELES (Reuters) - McDonald's Corp on Wednesday said that it would begin curbing the use of the high value human antibiotics in its global chicken supply in 2018, as the fast-food giant joins a broad effort to battle dangerous superbugs. Roche says FDA grants priority review to hemophilia drug emicizumab ZURICH (Reuters) - Swiss pharma group Roche said the U.S. Food and Drug Administration (FDA) granted priority review to its emicizumab for hemophilia A with inhibitors. Novartis receives EU approval for breast cancer drug Kisqali ZURICH (Reuters) - Novartis AG said its drug Kisqali (ribociclib) received European Union approval as first-line treatment for a tough-to-treat breast cancer, bolstering the Swiss drugmaker's bid to challenge U.S. rival Pfizer's Ibrance. New data boosts case for extended use of AstraZeneca heart drug LONDON (Reuters) - AstraZeneca's blood-thinner Brilinta cuts the risk of cardiovascular death by 29 percent in patients with a history of past heart attacks who keep taking it beyond the standard 12-month initial period, according to new clinical trial data. Vision loss associated with cognitive decline, dementia (Reuters Health) - Hearing impairment is already linked to a heightened risk of cognitive decline in old age, and a new study suggests that impaired vision may carry the same risk. Brain activity tied to blood pressure during stress (Reuters Health) - Brain scans obtained during psychological stress might someday help doctors identify people who are at higher risk for heart disease, a new study suggests. Massive California verdict expands J&J's talc battlefield NEW YORK (Reuters) - A massive California verdict in a lawsuit alleging Johnson & Johnson's talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said. Weak patient admissions to bug hospital operators through 2018 (Reuters) - Weak patient admissions that plagued U.S. hospital operators in the June quarter are likely to persist through 2018, as patients fret about soaring out-of-pocket costs and the future of Obamacare remains uncertain. Blacks with prostate cancer less likely to get ideal treatment (Reuters Health) - Black men with riskier prostate cancers may be less likely than their white counterparts to get aggressive treatment that can give them the best survival odds, a recent U.S. study suggests. Many heart failure patients don't recognize the risks of their illness (Reuters Health) - Even though doctors think most people with heart failure have a high likelihood of requiring a heart transplant or dying from complications of their illness, a small U.S. study suggests that many patients see a much rosier picture of their future. Related Video Students design solar-powered car to help Egypt's disabled In Montana's Indian country, tribes take opposite sides on coal A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook